Advertisement
Screener

MACROGENICS, INC. (MGNX) Restructuring Reserve, Current

2.8 / 5 stars · 68/120 Roast Me

MACROGENICS, INC. Restructuring Reserve, Current

MACROGENICS, INC. (MGNX) had Restructuring Reserve, Current of $0 as of 2018-09-30, per its 10-Q filed 2018-11-07.

Discontinued › Notes

us-gaap:RestructuringReserveCurrent · last filed 2018-11-07

  • 2018-09-30: Restructuring Reserve, Current $0.00.
  • 2018-06-30: Restructuring Reserve, Current $0.00.
  • 2018-03-31: Restructuring Reserve, Current $0.00.
  • 2017-12-31: Restructuring Reserve, Current $298.00K.
Period endRestructuring Reserve, CurrentRestructuring Reserve, Current as first filed
2018-09-30$0.00
10-Q · filed 2018-11-07
2018-06-30$0.00
10-Q · filed 2018-08-07
2018-03-31$0.00
10-Q · filed 2018-05-07
2017-12-31$298.00K
10-Q · filed 2018-11-07
2017-09-30$715.00K
10-Q · filed 2017-11-08
2017-06-30$1.12M
10-Q · filed 2017-08-02
2017-03-31$1.51M
10-Q · filed 2017-05-03
2016-12-31$1.59M
10-K · filed 2018-02-27
2016-09-30$1.52M
10-Q · filed 2016-11-02
2016-06-30$1.46M
10-Q · filed 2016-08-03
2016-03-31$2.08M
10-Q · filed 2016-05-04
2015-12-31$2.02M
10-K · filed 2017-02-28
2015-09-30$1.96M
10-Q · filed 2015-11-04
2015-06-30$1.90M
10-Q · filed 2015-08-05
2015-03-31$1.70M
10-Q · filed 2015-05-06
2014-12-31$1.64M
10-K · filed 2016-02-29
2014-09-30$1.59M
10-Q · filed 2014-11-12
2014-06-30$1.54M
10-Q · filed 2014-08-05
2014-03-31$1.49M
10-Q · filed 2014-05-06
2013-12-31$1.44M
10-K · filed 2015-03-03
$1.44M
10-K · filed 2014-03-20
2013-09-30$1.23M
10-Q · filed 2013-11-12
2012-12-31$628.77K
10-K · filed 2014-03-20

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Pyxis Oncology, Inc. (PYXS)United States$0.244B
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Lyell Immunopharma, Inc. (LYEL)United States$0.248B-1.32
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Akebia Therapeutics, Inc. (AKBA)United States$0.255B-10.35